NuVasive, Inc. (NUVA) Social Stream



NuVasive, Inc. (NUVA): $51.47

0.48 (+0.94%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Nuvasive Inc (NUVA) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering NUVA.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-10 11 $90 $48 $69.583 $57.12 21.82%
2021-11-16 11 $90 $48 $67.083 $57.12 17.44%
2021-12-10 12 $90 $48 $66.538 $57.12 16.49%
2021-12-17 11 $90 $50 $67.25 $57.12 17.73%
2021-12-21 9 $90 $50 $66.545 $57.12 16.5%
2022-01-25 9 $90 $50 $66.363 $57.12 16.18%
2022-02-15 8 $90 $50 $66.363 $57.12 16.18%
2022-02-24 9 $90 $50 $66.5 $57.12 16.42%
2022-02-25 9 $80 $50 $62.222 $57.12 8.93%
2022-03-28 10 $80 $50 $61.8 $57.12 8.19%

The Trend in the Analyst Price Target


NUVA's average price target has moved down $11.7 over the prior 46 weeks.

NUVA reports an average of 19.19% for its upside potential over the past 51 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-12-17 9 90 50 67.250 48.44 38.83%
2021-12-17 11 90 50 67.909 48.44 40.19%
2021-12-17 9 90 50 67.909 48.44 40.19%
2021-12-21 9 90 50 66.545 50.42 31.98%
2022-01-12 9 90 50 66.363 54.33 22.15%

NUVA Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.9 5 2 2 0 0 10

The Trend in the Broker Recommendations


Over the past 21 months, NUVA's average broker recommendation rating improved by 0.28.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In the context of all US stocks, Nuvasive Inc's variance in analysts' estimates is lower than -917.96% of them.
  • To contextualize these metrics, consider that out of Healthcare stocks, Nuvasive Inc's upside potential (average analyst target price relative to current price) is higher than 221.45% of them.
  • To contextualize these metrics, consider that out of stocks in the mid market cap category, Nuvasive Inc's number of analysts covering the stock is greater than 1095.05% of them.
  • In the context of Healthcare stocks, Nuvasive Inc's average analyst price target is higher than 986.86% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Medical Equipment industry with the ratings most similar to Nuvasive Inc are NARI, MMSI, and LUNG.

Is NUVA a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4515 seconds.